Something strange is happening in our industry, and most people haven't noticed it yet.
Two forces are reshaping dental laboratory work in opposite directions. Digital technology is transforming how routine restorations are designed and produced, raising the floor for quality and speed across the board. Meanwhile, implant work is being pulled in a completely different direction: upstream, further from the chair, deeper into planning, diagnostics, and clinical decision-making.
These two movements are happening simultaneously. And they have completely different implications for the relationship between surgeon and lab.
Let's start with the part everyone can see. AI-assisted design, robotic finishing, and platform-scale manufacturing are changing the economics of routine restorative work. A venture-backed lab in the United States recently described its model as doing for dental labs what modern factories did for smartphones. They produce thousands of units per day. They offer AI-optimised posteriors and provide free scanners to lock practices into their ecosystem.
Their bet is simple: that technology and scale can replace the relationship between clinician and technician. That if the scan is clean and the prep is textbook, a production facility can deliver a predictable result without the surgeon ever speaking to the person who designed their case.
For the simplest posterior work, that bet may hold. But restorative dentistry is rarely that simple. Anterior aesthetics require judgment that no algorithm has mastered. Complex shade matching across adjacent natural teeth demands an eye trained over thousands of cases, not thousands of data points. Multi-unit cases, long-span bridges, and occlusal rehabilitation all depend on a technician who understands not just the geometry of the preparation but the clinical context surrounding it.
Digital tools have undeniably improved restorative quality across the industry. At Nexus, we use them extensively. But we use them as instruments in the hands of experienced technicians, not as replacements for them. The difference between a lab that uses AI to assist its clinicians and a lab that uses AI to replace them is not a technical distinction. It is a philosophical one, and it shows in the work.
The downstream current is real. But the assumption that speed and scale alone will define the future of restorative dentistry is, in my view, premature.
Implant work is moving in the opposite direction, and this is where the conversation gets genuinely interesting.
Today, with prosthetically driven planning, guided surgery, and immediate loading protocols becoming standard practice, the lab's involvement increasingly begins before the surgeon picks up a handpiece. We are reviewing CBCT data alongside intraoral scans, assessing bone density in relation to planned prosthetic outcomes, and identifying cases where the restorative goal and the surgical reality do not align before anyone commits to a surgical plan.
This is the antithesis of fabrication. We see it as clinical collaboration, and it is moving the lab's contribution further upstream each year.
I want to be specific here, because ‘clinical partnership’ is one of those phrases that every lab in the country claims but very few actually deliver.
At Nexus, upstream involvement means more than just processing cases; it signifies a true clinical partnership. When complex cases arrive, our diagnostics team reviews them proactively, not after production begins, fostering trust and ensuring that our collaboration enhances clinical decision-making and patient care.
It means we assess scan quality at the point of entry, because we have learned, through thousands of cases, that approximately 70 to 80 per cent of problem cases can be traced back to the initial scan stage. Catching that at intake reassures surgeons that potential issues are managed proactively, saving everyone time and stress.
It means we maintain surgeon-specific case intelligence. When we receive a case from a surgeon we have worked with for years, we do not treat it as a blank slate. We know their preferred implant systems and their clinical tendencies. We also know the cases where they want us to flag concerns and the cases where they want us to proceed with confidence. That institutional memory is built over hundreds of interactions, and it cannot be replicated by onboarding software.
It means that when we identify a potential issue, whether that is a scan body discrepancy, a questionable implant angulation relative to the planned restoration, or a tissue concern that could compromise aesthetics, we raise it before committing resources. Not as a defensive measure to protect the lab from remakes, but because the earlier a concern is raised, the more options the surgeon has to address it, and the better the patient's outcome.
This is the part of the lab relationship that a production platform, however well-funded and however technologically sophisticated, structurally cannot provide. Not because they lack talent, but because their model is optimised for throughput rather than the kind of slow, case-specific, relationship-dependent clinical reasoning that complex implant work demands.
Here is a practical way to evaluate whether your current lab relationship is a clinical partnership or a fulfilment arrangement. Ask yourself these questions:
Does your lab contact you before starting a complex case, or only when something has already gone wrong?
Can you name the technician who designs your work? Do they know your name?
Has your lab ever pushed back on a plan because they believed it would compromise the restoration? Not to cause difficulty, but because they had seen the outcome before and wanted to save you from it?
Has your lab ever adapted its approach based on specific aspects of your clinical style, preferred materials, scanner characteristics, or patients' typical presentations?
If the answer to most of these is no, you do not have a lab partner. You have a supplier. And for implant work in particular, the difference between the two is not marginal; it is structural.
Here is the part that keeps me thinking. As AI and robotics continue to mature, certain elements of the production process, such as milling, initial design proposals, and aspects of finishing, will become increasingly automated. This is not speculation because we are already seeing it. At Nexus, we welcome these developments because they free our technicians to focus on the decisions that actually require expertise: the aesthetic judgment, the risk assessment, the clinical reasoning that turns a technically adequate restoration into an exceptional one.
But here is the counterintuitive insight: as the production side of lab work becomes more automated, the upstream conversation, the planning, the diagnostics, the case-specific clinical thinking, becomes the only part of the relationship that cannot be replicated by technology, and this is disproportionately true for implant work.
Some commentators predict a future where chairside milling handles an increasing share of simple single-unit restorations. That technology is developing, and it will find its place. But the vast majority of restorative work, and virtually all implant work, involves a level of complexity that demands more than a single-appointment, single-operator workflow. Anterior aesthetics, tissue management, prosthetic-to-surgical alignment, long-term occlusal planning: these require the kind of collaborative thinking that happens between a skilled clinician and an experienced lab team, not between a clinician and a milling unit.
I recently wrote about the concept of strategic inefficiency: the idea that, in an age of automation, the practices and labs that thrive will be those that deliberately invest time and expertise in the parts of the process that machines cannot replicate. Implant planning is the clearest example of this principle in action.
A lab that invests primarily in platform efficiency is betting that production speed alone will be enough to win and retain clinicians. For the simplest, most transactional cases, that bet may pay off.
Whereas a lab that invests in clinical partnerships, scan triage, diagnostic design loops, and surgeon-specific case intelligence is building something that compounds over time. Every case adds to the shared knowledge between the lab and the surgeon. Each intervention strengthens trust, just as every successful outcome reinforces the relationship.
One model scales horizontally, the other deepens vertically. Both have a place, but for the implant surgeon, only one of them creates genuine, lasting value.
I am not going to pretend this is a neutral observation. Nexus has deliberately chosen to invest in the upstream model, and we apply that thinking across everything we do, not just implant work.
The same scan triage that catches a problematic CBCT before an implant case enters planning also catches a marginal preparation scan before a crown enters design. The same technician who maintains a decade-long relationship with an implant surgeon also knows how that clinician's anterior cases should be characterised, how they like their emergence profiles shaped, and what shade nuances their patients expect. The upstream philosophy is not reserved for complex cases. It is how we work.
We have built our entire implant workflow around early-stage case involvement, from the moment a scan arrives through diagnostics, planning, and co-reviewed design approval, before a single unit enters production.
We are the first official UK MGuide Centre and a leading SMOP service provider. We handle CT alignment, nerve tracking, and base plan setup so that our surgeons spend minutes reviewing and approving, not hours planning from scratch.
More than the technology, though, we have invested in people. Our diagnostics team reviews every complex case at intake. Our senior technicians maintain long-term relationships with the surgeons they serve. I still personally finalise our Atlantis designs, over 10,000 and counting, because the sign-off matters as much as the software.
We do this because we believe the future of implant dentistry belongs to the labs and surgeons who work together before surgery, not just after.
The downstream current is real, and digital tools are raising standards across the board. We use them, and we champion them. But for implant surgeons who want a lab that thinks with them, not just builds for them, the upstream current is where the value lives.
And that is where you will find us.
If you are an implant surgeon exploring what a genuine lab partnership looks like, we welcome the conversation. [Get your exclusive welcome pack].
